Institutions / Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC
CIK 1777015 · Institution · as of Dec 31, 2025
Portfolio value
$1.05B
Positions
100
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 100 →
| Company | Value | % of portfolio |
|---|---|---|
| Boston Scientific Corp | $47.73M | 4.5% |
| Insulet Corp | $40.04M | 3.8% |
| Dexcom Inc | $38.99M | 3.7% |
| Stryker Corp | $37.07M | 3.5% |
| CVS HEALTH Corp | $35.73M | 3.4% |
| McKesson Corp | $29.82M | 2.8% |
| KalVista Pharmaceuticals Inc | $28.56M | 2.7% |
| MBX Biosciences, Inc.MBX | $27.93M | 2.7% |
| Kiniksa Pharmaceuticals International, plc | $27.44M | 2.6% |
| Masimo Corporation | $26.01M | 2.5% |
| LivaNova PLC | $25.28M | 2.4% |
| Terns Pharmaceuticals, Inc. | $25.08M | 2.4% |
| Viridian Therapeutics, Inc. | $24.52M | 2.3% |
| Arcus Biosciences, Inc. | $23.08M | 2.2% |
| Upstream Bio, Inc.UPB | $22.66M | 2.2% |
| Qiagen NV | $22.23M | 2.1% |
| Amicus Therapeutics Inc | $21.18M | 2.0% |
| EyePoint, Inc. | $19.88M | 1.9% |
| Alnylam Pharmaceuticals Inc | $18.97M | 1.8% |
| Neurocrine Biosciences Inc | $16.27M | 1.5% |
| Waters Corp | $15.91M | 1.5% |
| Mettler-Toledo International Inc | $15.32M | 1.5% |
| Mineralys Therapeutics IncMLYS | $14.89M | 1.4% |
| Stoke Therapeutics, Inc. | $13.65M | 1.3% |
| Agilent Technologies Inc | $13.61M | 1.3% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.